Cardiovascular Genetics | Inherited Heart Disease Testing | Cytogenomix® Malaysia
Inherited Cardiac Conditions

Cardiovascular Genetics

Comprehensive genetic testing for inherited heart conditions including cardiomyopathies, arrhythmias, familial hypercholesterolemia, and aortopathies.

12+ CARDIO PANELS
81+ GENES ANALYZED
1:200 CARRY A CARDIOMYOPATHY VARIANT
2-3 WEEKS TAT

Understanding Inherited Heart Conditions

Many cardiovascular conditions have a genetic basis and can run in families. Identifying the underlying genetic cause enables:

  • Accurate Diagnosis: Confirm suspected inherited heart conditions
  • Risk Stratification: Identify at-risk family members before symptoms develop
  • Sudden Cardiac Death Prevention: Implement preventive measures
  • Family Planning: Options for at-risk family members
  • Treatment Guidance: Personalized management strategies

Our cardiovascular genetics panels are designed to identify clinically actionable variants in genes associated with structural heart disease, electrical abnormalities, and vascular conditions.

Cardiovascular Genetics

Inherited Cardiovascular Conditions

Four main categories of genetic heart disease

Cardiomyopathies

  • Hypertrophic Cardiomyopathy (HCM)
  • Dilated Cardiomyopathy (DCM)
  • Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
  • Restrictive Cardiomyopathy
  • Left Ventricular Non-Compaction (LVNC)
MYH7 MYBPC3 TNNT2 TNNI3 LMNA

Primary Arrhythmias

  • Long QT Syndrome (LQTS)
  • Brugada Syndrome
  • Catecholaminergic Polymorphic VT (CPVT)
  • Short QT Syndrome
  • Progressive Cardiac Conduction Disease
KCNQ1 KCNH2 SCN5A RYR2 CACNA1C

Lipid Disorders

  • Familial Hypercholesterolemia (FH)
  • Familial Combined Hyperlipidemia
  • Sitosterolemia
  • Lipoprotein(a) Elevation
LDLR APOB PCSK9 LDLRAP1

Aortopathies

  • Marfan Syndrome
  • Loeys-Dietz Syndrome
  • Vascular Ehlers-Danlos Syndrome
  • Familial Thoracic Aortic Aneurysm
FBN1 TGFBR1 TGFBR2 COL3A1 ACTA2

Pulmonary Hypertension

  • Heritable Pulmonary Arterial Hypertension
  • Pulmonary Veno-occlusive Disease
BMPR2 ACVRL1 ENG SMAD9

Other Cardiac Conditions

  • Congenital Heart Disease
  • Cardiac Amyloidosis
  • Cardiac Sarcoidosis (genetic susceptibility)
  • RASopathies (Noonan syndrome)

Inherited Cardiomyopathies

Genetic disorders of heart muscle structure and function

Hypertrophic Cardiomyopathy (HCM)

Most common inherited heart disease (1:500). Thickening of heart muscle, risk of sudden cardiac death, heart failure, and atrial fibrillation. Autosomal dominant inheritance with variable penetrance.

MYH7 MYBPC3 TNNT2 TNNI3 TPM1 MYL2 MYL3 ACTC1

Dilated Cardiomyopathy (DCM)

Enlargement and weakening of heart chambers, leading to heart failure. Highly heterogeneous with over 50 associated genes. May present with conduction disease, arrhythmias, and sudden death.

LMNA MYH7 TNNT2 TTN BAG3 RBM20 PLN DSP

Arrhythmogenic Cardiomyopathy (ARVC)

Progressive replacement of heart muscle with fibrous-fatty tissue, primarily affecting right ventricle. High risk of ventricular arrhythmias and sudden death, especially in young athletes.

PKP2 DSP DSG2 DSC2 JUP TMEM43 PLN

Primary Arrhythmia Syndromes

Genetic disorders of cardiac ion channels and electrical function

Long QT Syndrome (LQTS)

Autosomal dominant (Romano-Ward) or recessive (Jervell and Lange-Nielsen)

Prolonged QT interval on ECG, increased risk of torsade de pointes and sudden death. Triggers include exercise, emotion, and certain medications.

1:2,500

Brugada Syndrome

Autosomal dominant

Characteristic ECG pattern (coved-type ST elevation in V1-V3), risk of ventricular fibrillation and sudden death, often during sleep or with fever.

1:5,000

Catecholaminergic Polymorphic VT (CPVT)

Autosomal dominant (RYR2) or recessive (CASQ2)

Stress-induced bidirectional/polymorphic ventricular tachycardia in structurally normal hearts. High mortality without treatment.

1:10,000

Short QT Syndrome

Autosomal dominant

Shortened QT interval, increased risk of atrial and ventricular fibrillation. Rare but highly lethal.

Very rare

Progressive Cardiac Conduction Disease

Autosomal dominant

Progressive slowing of cardiac conduction, leading to heart block and pacemaker requirement. Often associated with cardiomyopathy (especially LMNA).

Early Repolarization Syndrome

Complex

J-point elevation on ECG, associated with idiopathic ventricular fibrillation in some individuals.

Familial Hypercholesterolemia (FH)

One of the most common inherited metabolic disorders, FH causes severely elevated LDL cholesterol from birth, leading to premature atherosclerotic cardiovascular disease.

1:250
Heterozygous FH prevalence
1:160,000
Homozygous FH prevalence
20x
Increased CAD risk

Key Genes:

LDLR APOB PCSK9 LDLRAP1

LDLR mutations account for ~90% of cases

Familial Hypercholesterolemia

Inherited Aortopathies

Genetic conditions affecting the aorta and connective tissue

Marfan Syndrome

Autosomal dominant connective tissue disorder affecting cardiovascular, skeletal, and ocular systems. Progressive aortic root dilation leads to risk of dissection.

FBN1

Loeys-Dietz Syndrome

Aggressive aortopathy with arterial tortuosity, hypertelorism, and bifid uvula. Higher risk of dissection at smaller aortic diameters.

TGFBR1 TGFBR2 SMAD3 TGFB2 TGFB3

Vascular Ehlers-Danlos Syndrome

Severe connective tissue disorder with risk of arterial, uterine, and intestinal rupture. Reduced life expectancy.

COL3A1

Familial Thoracic Aortic Aneurysm

Non-syndromic thoracic aortic aneurysms and dissections without other systemic features. Variable penetrance and expression.

ACTA2 MYH11 MYLK PRKG1 LOX

Cardiovascular Testing Panels

Comprehensive options for inherited cardiac conditions

Comprehensive Cardiomyopathy Panel

50+ genes
  • Hypertrophic cardiomyopathy (HCM)
  • Dilated cardiomyopathy (DCM)
  • ARVC
  • Left ventricular non-compaction
  • Restrictive cardiomyopathy

Comprehensive Arrhythmia Panel

40+ genes
  • Long QT syndrome (LQTS)
  • Brugada syndrome
  • CPVT
  • Short QT syndrome
  • Conduction disease

Familial Hypercholesterolemia Panel

4 genes + risk variants
  • LDLR (copy number analysis included)
  • APOB
  • PCSK9
  • LDLRAP1 (recessive FH)

Aortopathy Panel

20+ genes
  • Marfan syndrome
  • Loeys-Dietz syndrome
  • Vascular Ehlers-Danlos
  • Familial thoracic aortic aneurysm

Comprehensive Cardio Panel

100+ genes
  • All cardiomyopathies
  • All primary arrhythmias
  • Familial hypercholesterolemia
  • Aortopathies
  • RASopathies

Sudden Death Panel

80+ genes
  • Post-mortem genetic testing
  • All major arrhythmia genes
  • Cardiomyopathy genes
  • Aortopathy genes

Who Should Consider Cardiovascular Genetic Testing?

Indications for inherited cardiac condition testing

Personal History

  • Diagnosed cardiomyopathy
  • Unexplained syncope
  • Aborted cardiac arrest
  • Documented arrhythmia
  • Early-onset CAD

Family History

  • Sudden unexplained death
  • Known familial variant
  • Multiple family members with cardiomyopathy
  • Early-onset heart disease

Clinical Findings

  • Abnormal ECG
  • LVH on echocardiogram
  • Dilated aorta
  • Extremely high cholesterol

Cascade Testing for Family Members

When a pathogenic variant is identified in an affected individual, testing at-risk family members can identify those who carry the variant and implement preventive measures before symptoms develop.

50%
First-degree relatives may carry the variant
100%
Preventable sudden death in identified carriers

Frequently Asked Questions

Common questions about cardiovascular genetic testing

What is the difference between genetic testing for cardiomyopathies vs. arrhythmias?

Cardiomyopathy panels focus on genes affecting heart muscle structure and function, while arrhythmia panels focus on ion channel genes affecting electrical activity. Many conditions overlap, and comprehensive panels include both.

How long does it take to get results?

Most cardiovascular panels have a turnaround time of 2-3 weeks from sample receipt. Urgent testing may be available for certain indications.

What sample is required?

3-5 mL whole blood in EDTA tube (purple top). For post-mortem testing, blood or tissue samples can be accepted.

What is cascade testing and why is it important?

Cascade testing is the systematic testing of at-risk family members when a pathogenic variant is found. It identifies individuals who can benefit from preventive care and surveillance.

Can children be tested for inherited heart conditions?

Yes, but testing is typically reserved for those with symptoms or a strong family history, as results may impact clinical management and preventive strategies.

Will insurance cover cardiovascular genetic testing?

Most insurance plans cover testing for individuals meeting clinical criteria. Our team can assist with pre-authorization and insurance verification.

Ready to Learn About Inherited Heart Conditions?

Our cardiovascular genetics specialists and genetic counselors are ready to help you and your patients understand inherited cardiac risk.

Or call us: +603-1234-5678